Claims filing process made easy
Litigation | DiDi Global Inc. |
|---|---|
Settlement Fund | $740 Million |
Class Period | June 6, 2021 - July 2, 2021 |
Description | DiDi is a multinational holding company whose principal operations are based in China. DiDi is engaged in providing ride hailing services, and a variety of ancillary mobility, transport, and internet commerce businesses. This action arises out of alleged misrepresentations and omissions contained in the Registration Statement and alleged deceptive conduct in connection with DiDi’s June 30, 2021 IPO. Class members are entities that purchased DiDi ADSs during the class period, June 30, 2021 through July 21, 2021. |
Litigation | Rivian Automotive, Inc. |
|---|---|
Settlement Fund | $250 Million |
Class Period | Nov. 10, 2021 - March 10, 2022 |
Description | As a result of materially false and/or misleading statements and omissions of material facts and risks arising from the alleged fact that the bill of materials cost of Rivian’s R1 electric vehicle far exceeded the sales price at which these vehicles were being offered to customers, requiring Rivian to increase prices and resulting in damage to class members during Rivian’s IPO. Class members are entities who purchased or otherwise acquired Rivian Class A common stock between November 10, 2021 and March 10, 2022. |
Litigation | Celgene Corp. Common Stock |
|---|---|
Settlement Fund | $239 Million |
Class Period | April 27, 2017 - April 27, 2018 |
Description | As a result of the materially false and/or misleading statements and/or failures to disclose material facts regarding Celgene’s development of multiple sclerosis drug Ozanimod and substantial impediments to the expansion of the market for Otezla. Class members are entities who purchased common stock between April 27, 2017 and April 27, 2018. |
Litigation | Acadia Healthcare Group Securities Litigation/TN |
|---|---|
Settlement Fund | $179 Million |
Class Period | April 30, 2014 - Nov. 15, 2018 |
Description | As a result of materially false and/or misleading statements and omissions of material facts and engaged in a scheme to defraud during the class period concerning the quality of care and adequacy of staffing at Acadia’s facilities and their compliance with applicable laws and regulations and Acadia’s expected financial performance for its operations in the U.K. Class members are all entities who purchased or otherwise acquired Acadia Healthcare Company, Inc. common stock during the class period, April 30, 2014 through November 15, 2018. |
Litigation | Wells Fargo Common (SEB) |
|---|---|
Settlement Fund | $85 Million |
Class Period | Feb. 24, 2021 - June 9, 2022 |
Description | As a result of materially false and/or misleading statements and omissions regarding the company’s diversity hiring initiative being operated in a manner that led to widespread “fake” interviews of diverse candidates and the truth was published in an article on June 9, 2022, resulting in shareholder losses. Class members are entities who purchased or otherwise acquired Wells Fargo & Company common stock between February 24, 2021 and June 9, 2022, inclusive, and were damaged thereby. |